ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
28.01
-0.17
(-0.60%)
At close: May 10 4:00PM
27.98
-0.20
( -0.71% )
After Hours: 4:36PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
27.98
Bid
-
Ask
-
Volume
25,513,122
27.92 Day's Range 28.28
25.20 52 Week Range 40.365
Market Cap
Previous Close
28.18
Open
28.24
Last Trade
17
@
27.97
Last Trade Time
16:36:39
Financial Volume
$ 714,799,863
VWAP
28.017
Average Volume (3m)
43,490,687
Shares Outstanding
5,646,778,425
Dividend Yield
5.90%
PE Ratio
74.63
Earnings Per Share (EPS)
0.38
Revenue
58.5B
Net Profit
2.12B

About Pfizer Inc

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers includ... Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
New York, New York, USA
Founded
1970
Pfizer Inc is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker PFE. The last closing price for Pfizer was $28.18. Over the last year, Pfizer shares have traded in a share price range of $ 25.20 to $ 40.365.

Pfizer currently has 5,646,778,425 shares outstanding. The market capitalization of Pfizer is $158.17 billion. Pfizer has a price to earnings ratio (PE ratio) of 74.63.

Pfizer (PFE) Options Flow Summary

Overall Flow

Bearish

Net Premium

-21M

Calls / Puts

12.90%

Buys / Sells

73.68%

OTM / ITM

6.06%

Sweeps Ratio

0.01%

PFE Latest News

Bain Capital in Talks to Acquire PowerSchool; Blackstone Emerges Victorious in Hipgnosis Bidding War, and More News

Bain Capital (NYSE:BCSF), PowerSchool Holdings (NYSE:PWSC) – Bain Capital is in talks to purchase PowerSchool, an educational software provider, in a private deal that could value the...

Pfizer Announces New Chief Strategy and Innovation Officer

Pfizer Inc. (NYSE: PFE) today announced that Andrew Baum, M.D., will join the company as Chief Strategy and Innovation Officer, Executive Vice President. Dr. Baum will be a member of Pfizer’s...

CVS Health, Starbucks, Shares Weaker; Pinterest Soars

Shares of CVS Health (NYSE:CVS) are moving sharply lower in pre-market trading after the drugstore chain and pharmacy benefit manager reported weaker than expected first quarter results and cut...

Pfizer Reports First-Quarter 2024 Results

Solid First-Quarter Results Reflect Continued Growth of Key Products and Progress in Executing 2024 Priorities First-Quarter 2024 Revenues of $14.9 Billion Expected Decline in Comirnaty(1) and...

TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer

Company Announcement Full approval based on global Phase 3 study demonstrating overall survival benefit of TIVDAK compared to chemotherapy TIVDAK is the first antibody-drug conjugate in this...

Pfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual Meeting

More than 50 abstracts, including 11 oral presentations, span Pfizer’s robust portfolio of approved and pipeline therapies across its key tumor areas and core scientific modalities New five-year...

Anglo American Rejects BHP Group’s Offer, Toyota Invests $1.4 Billion in Indiana, and More News

BHP Group (NYSE:BHP) – Anglo American has rejected BHP’s acquisition proposal of $38.88 billion, stating it significantly undervalues the company and its future prospects. The offer...

U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B

A one-time dose of BEQVEZ has reduced bleeds post-treatment compared to standard of care with a median of zero bleeds (range 0 to 19) after up to three years of follow-up, providing sustained...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.120.43072505384127.8628.4927.325452355328.00796769CS
41.736.5904761904826.2528.4925.24618324626.70071623CS
120.421.5239477503627.5628.6925.24349068727.02376413CS
26-1.77-5.9495798319329.7530.7525.24453843727.65314001CS
52-10.72-27.700258397938.740.36525.23572138430.60144764CS
156-11.85-29.751443635539.8361.7125.22977915140.9373728CS
260-12.65-31.134629584140.6361.7125.22944669739.39660826CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AKTSAkoustis Technologies Inc
$ 0.6274
(10.44%)
4.11k
VCNXVaccinex Inc
$ 6.20
(7.83%)
2.02k
JANJanOne Inc
$ 4.30
(7.23%)
397.91k
WAVDWaveDancer Inc
$ 3.18
(6.71%)
6.82k
XMTRXometry Inc
$ 17.11
(4.97%)
8.32k
AEHLAntelope Enterprise Holdings Ltd
$ 1.55
(-18.85%)
49.78k
DRMADermata Therapeutics Inc
$ 0.3199
(-10.82%)
3.75k
ALBTAvalon GloboCare Corporation
$ 0.3039
(-10.62%)
209.75k
SCKTSocket Mobile Inc
$ 1.16
(-9.38%)
1.43k
PRTGPortage Biotech Inc
$ 0.2315
(-8.24%)
7.94k
HSTHost Hotels and Resorts Inc
$ 18.34
(0.00%)
2.8M
GWAVGreenwave Technology Solutions Inc
$ 0.0448
(2.05%)
1.89M
NVAXNovavax Inc
$ 9.08
(2.25%)
1.81M
AKANAkanda Corporation
$ 0.0922
(-6.11%)
1.33M
LIDRAEye Inc
$ 2.58
(0.00%)
1.21M

PFE Discussion

View Posts
IHuser IHuser 54 minutes ago
imo... don't ask me how SLY and Wrank knew NANO was sleepy time...but they had an eye on eeem.... and his lips were cracked and bleeding~

...which leads one to consider another PFE product was called for....to help NANO rest.




PFE



IHuser
👍️0
IHuser IHuser 2 hours ago
imo...Vex....I never required Narcan, or Viagra, my wife would not allow it in the house and my ex husbands would not either.....but we had a special pet bat we named NANO....and my Vipers always knew when NANO was asleep~


PFE



IHuser
👍️0
Vexari Vexari 7 hours ago
Toxicity through a slow poisoning process

~~~ Found in the vaccine, food and energy drinks ~~~
(1:25:20)

All dripping with venoms

michaelj5326
🤡 1 🦤 1
PowerPlay1 PowerPlay1 21 hours ago
#PFE $PFE $45-$55 Longterm.
👍️0
Vexari Vexari 1 day ago
To cover up disturbing side effects

~~~ Reality has its way ~~~
(18:06)

Of shining light

Not fake news
💩 1 🤡 1 🤪 1 🦃 1 🦤 1
Dox_Dox Dox_Dox 1 day ago
I don’t short stocks. Might be my first one ever here. Directionless. Tons of hate. Corporate malfeasance malfunction ?
👍️0
rahrah rahrah 2 days ago
Hope you enjoy your rabbit hole, aluminum antenna, and reading “Batchit”
👍️0
Monroe1 Monroe1 2 days ago
Now Japan...doesn't look like things are improving for mRNA junk.
https://www.bitchute.com/video/9kRkv6T1NyCs/
🦤 1
Monroe1 Monroe1 2 days ago
Did you listen to the that interview with words coming out of his mouth or do you suffer from Tinninitus due to the jabs? NO, you know it all without researching.
Oh, and did he lie before Congress? Ohh, well, a little white lie was all. AND millions died from protocols changed
especially for covid so docs would have to use the jabs and rendesivir... and now the world pays the price as the
true cost of the "pandemic" is catching up to the economy. And guess what, with EUA they dodged the liability!!
How convenient. Now why is this happening; Net Income Attributable to Common Shareholders DOWN 45% over 2023
with more losses mounting. No worry though, they have another pandemic or two coming... of course by November and of course
verified by a PCR false positive test. The not yet isolated but hyped bird flu, and of course a mutated covid that they have not isolated either....but not to worry!
Pfizer will come up with a product no matter what... no matter if it works or works in reverse. Can't lose with the MSM doing your free advertising.
What a joke. Too bad for those who got fooled and especially the honest folks who believed in the "system. Those days have come to screeching halt.
🦤 1
rahrah rahrah 2 days ago
Fauci, M.D. wasn’t confused in the least. It’s YOUR comprehension that’s confused!
👍️0
Monroe1 Monroe1 2 days ago
https://www.bitchute.com/video/ZnqZqSEZQbuu/
👍️0
Monroe1 Monroe1 2 days ago
yeah Fauci was confused ... only he changed his mind after padding his bank account. Makes good sense for the me me generation and to heck with your neighbor.

Catch up on the real science.
👍️0
rahrah rahrah 2 days ago
Sure doesn’t make any sense if your touting getting infected as a preventative, now does it
Yeah, get infected, and hope you live through it to acquire an immune response
👍️0
Monroe1 Monroe1 2 days ago
Remember this one? https://www.c-span.org/video/?c5008985/user-clip-dr-anthony-fauci-acknowledges-superiority-naturally-acquired-immunity-relative-vaccine-a
🦃 1
Monroe1 Monroe1 2 days ago
Sure thing. Who supports this study? WHO. Yeah right.
Antigen tests are insufficient and these stats are based on how many died and or severe cases. So many survive despite the vaccine, and sometimes the
"cure" is worse than the bite... as Pfizer knew/knows all too well.
So the focus should be on T-Cell responses but nooooo, it is too expensive to do that... and may just lead to a vax that actually is effective without the side effects.

From very recent Health Affairs "The lesson—for the current and any future pandemic—is that we urgently need to identify, develop, and evaluate optimal strategies—whether they be persuasive or coercive—to increase vaccine uptake and allocate resources where they will do the most good."

Forget the trials, just grant some EUA's and have at it.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710106/

Even some MSM are admitting the truth. https://www.nbcnews.com/health/health-news/natural-immunity-protective-covid-vaccine-severe-illness-rcna71027
💩 1 🤡 1 🦃 1
Monroe1 Monroe1 2 days ago
And on top of all that, we have Pfizer to go hard on cancer after the covid vax's boost up the cancer incidents way off the charts and now Pfizer agrees to settle over 10,000 Zantac lawsuits though it will not end them all. OUCH.
👍️0
axelvento axelvento 2 days ago
Vaccines Have Saved a Staggering 154 Million Lives in The Last 50 Years

https://www.sciencealert.com/vaccines-have-saved-a-staggering-154-million-lives-in-the-last-50-years
👍️0
axelvento axelvento 3 days ago
https://www.fiercebiotech.com/biotech/pfizer-reports-death-young-boy-dmd-who-participated-gene-therapy-trial
👍️0
Monroe1 Monroe1 4 days ago
PFE getting a bit puffy. They project about twice as much as there BioNtech says. They better do some firing, hiring and lots of buying especially as more lawsuits mount up almost weekly.

https://www.biospace.com/article/biontech-misses-q1-analyst-expectations-for-earnings-revenue-on-lowercovid-19-sales/?_gl=1*1643c2g*_up*MQ..*_ga*OTYwNDc4NzUuMTcxNDc0OTc0OQ..*_ga_DXDENFX4SY*MTcxNTAwMjIxMS4yLjAuMTcxNTAwMjIxMS4wLjAuMA..*_ga_Q90M6MWJZ4*MTcxNTAwMjIxMS4yLjAuMTcxNTAwMjIxMS4wLjAuMA..&_hsenc=p2ANqtz-8Mna_rQVBtzAnbRcd01wu-NXP5Uj9135JfbkmYcCiBqLKJD-zOgQMT_1_cUghgEy36orS64gM-29wSMt9sGmKLf5xhvw&_hsmi=305808870
👍️0
DewDiligence DewDiligence 4 days ago
PFE hiring suggests more M&A coming—Citi biotech_analyst_ to_head_business_development:

https://www.businesswire.com/news/home/20240506861564/en

Andrew Baum’s title will be EVP, Chief Strategy and Innovation Officer. He will report directly to PFE’s CEO.
👍️0
IHuser IHuser 6 days ago
imo...the stock market has not has the reach that ihub has delivered to counter a runaway horse....in recorded history~

...to my knowledge.


PFE



IHuser
🤡 1 🦃 1
IHuser IHuser 6 days ago
imo... hqhahahahaha......expect gap down to 20.00 pps on monday....PFE

...vex who said the stock market is not democratic~



PFE



IHuser
💩 1 🤡 1 🦃 1
DewDiligence DewDiligence 1 week ago
PFE/MRNA—1Q24 COVID-vaccine worldwide_market_share—>68/32 in favor of PFE.

https://www.accesswire.com/858697/moderna-reports-first-quarter-2024-financial-results-and-provides-business-updates

PFE’s 2024 guidance for Comirnaty sales is $5.0B (#msg-174337807); MRNA has not issued 2024 guidance for Spikevax, but rather for total corporate revenue including the not-yet-approved RSV vaccine.
👍️0
Monroe1 Monroe1 1 week ago
whoaaa, I may have to go short again.
https://www.biospace.com/article/pfizer-beats-q1-forecast-despite-20-percent-revenue-drop-cuts-four-pipeline-programs/?_hsenc=p2ANqtz--OLdTZI-I_rS5pe26rM9Mg7PBtfrimFDLAG2346fNraKuHvvHn1q9Pa3AOADjXX61BArfJt6UvmEZMhkDV6DRt-88R6g&_hsmi=305175185
👍️0
DewDiligence DewDiligence 1 week ago
PFE reports 1Q24 results—raises 2024 non-GAAP EPS guidance:

https://s28.q4cdn.com/781576035/files/doc_financials/2024/q1/Q1-2024-PFE-Earnings-Release.pdf

1Q24 highlights

• 1Q24 revenue was $14.9B, -19% YoY—but +11% YoY excluding COVID-related revenue.

• 1Q24 sales of Comirnaty (COVID vaccine) and Paxlovid were $354M and $2.0B, respectively.

• 1Q24 GAAP and non-GAAP EPS were $0.55 and $0.82, respectively. Both the GAAP and non-GAAP figures include a $0.11 benefit from a better settlement with the US government on expired lots of Paxlovid than the amount that PFE wrote off during 4Q23.

2024 full-year guidance

• 2024 non-GAAP EPS guidance is now $2.15-2.25, up $0.10 from the prior range. Both the old and the new guidance ranges include a negative $0.40 hit from SGEN, most of which stems from the net interest expense on the $43B of net debt PFE took on to fund the acquisition.

• 2024 sales guidance for Comirnaty (COVID vaccine) is $5B (down from $11.2B in 2023), unchanged from the prior guidance three months ago. ~90% of 2024 Comirnaty sales are expected to occur in 4Q23, due to seasonality.

• 2024 sales guidance for Paxlovid is $3B (no meaningful figure for 2023 due to the aforementioned write-off), unchanged from the prior guidance three months ago. Inasmuch as 1Q24 Paxlovid sales were $2.0B, the 2024 full-year guidance implies $1.0B of Paxlovid sales during 2Q24/3Q24/4Q24.

• 2024 sales guidance for legacy-Seagen sales is $3.1B.


4Q23 CC slides:
https://investors.pfizer.com/files/doc_financials/2023/q4/Q4-2023-Earnings-Charts-FINAL.pdf

CC prepared remarks (synched with slides):
https://s28.q4cdn.com/781576035/files/doc_financials/2023/q4/Q4-2023-Earnings-Conference-Call-Prepared-Remarks-FINAL.pdf
👍️0
ziploc_1 ziploc_1 1 week ago
-pfizer-genmab-cervical-cancer-therapy-wins-full-fda-approval

https://seekingalpha.com/news/4096045-pfizer-genmab-cervical-cancer-therapy-wins-full-fda-approval
👍️ 1
Vexari Vexari 2 weeks ago
Makes one wonder

If we all call the tune

Then the piper will lead us to reason
And a new day will dawn
For those who stand long

And the forests will echo with laughter

When all are one and one is all
To be a rock and not to roll


https://www.youtube.com/watch?v=CPSkNFODVRE
💤 1 💩 1 🤮 1
IHuser IHuser 2 weeks ago
imo... i told you guys without the retail investor fooled.....the stock will go underwater instantly~


see now what we can do?



PFE


IHuser
👍️ 1 💤 1 💩 1 🤡 1 🦃 1
IHuser IHuser 2 weeks ago
imo... Vex are we making a dent in clarifying who us is and who them is? By the chart....things are clearing up rapidly figuratively speaking~




PFE



IHuser
😎 1 🤡 1
IHuser IHuser 2 weeks ago
imo...it's looking like lights outl for Pfizer




PFE


IHuser
👍️ 1 🙊 1 🤡 1 🥜 1
DewDiligence DewDiligence 2 weeks ago
FDA approves PFE’s Beqvez gene-therapy for hemophilia-B:

https://www.businesswire.com/news/home/20240425269649/en

The US list price of $3.5M is the same as CSL’s Hemgenix (#msg-170520619).

p.s. Benveq should not be confused with PFE's Marstacimab for hemophilia A and hemophilia B (#msg-172016370), which is an antibody, not a gene therapy.
👍️0
Vexari Vexari 2 weeks ago
Ten days

Of darkness

In the middle of it
💩 1 🙊 1 🤡 1
Vexari Vexari 2 weeks ago
People will wake when it hits home

Bootstraps are an important tool

Psychologically speaking

Awareness is key
💤 1 💩 1 🤡 1
IHuser IHuser 2 weeks ago
imo... Vex i could only make it about one minute into that video my stomach can't take watching those people do that to that little girl......remember when i mentioned the possibility of violence at hospitals initiated by extremely angry estranged parents (fathers) upon learning what they were doing to kids...?


PFE


IHuser
👍️0
Vexari Vexari 2 weeks ago
Never forget what they did

~~~ In the name of health ~~~
(1:32)

Smoke&Mirrors
💤 1 🤡 1 🦃 1
IHuser IHuser 2 weeks ago
imo...it is a great day for capital punishment.... don't you agree?.... 4~23~24 is a pallindrome

PFE


IHuser
👍️0
Vexari Vexari 2 weeks ago
Capital punishment

~~~ Is the only answer ~~~
(15:06)

For those so worthy

After the FDA approved the original vaccine

Pfizer then switched to batch 2

Which included cancer causing carcinogens

And a lot more

To cause as much harm as possible. wil paranormal
💩 1 🤡 1 🤥 1 🤪 1 🦃 1
Lime Time Lime Time 3 weeks ago
25 bucks for a save the world vaccine company.

Are there idiots out there still taking these water jabs?

What a huge scam this company is. Chart shows it all.
💩 2 🙈 1 🙊 1 🤡 1
IHuser IHuser 3 weeks ago
imo.... @@....my boys are comin for you bud~ PFE


PFE


IHuser
👍️0
IHuser IHuser 3 weeks ago
imo... SWAB neutralized.....now we want goofball ferrari PFE


PFE


IHuser
🙊 1 🤡 1
Monroe1 Monroe1 4 weeks ago
I've used it for decades. Effective and safe. Now this:
I especially like PG.

Studying the ways viruses affect cellular pathways during infection may help in developing treatments for infectious diseases such as COVID-19.
A new study, conducted by researchers at the University of Alberta and published in the npj Viruses journal, found that certain cancer treatment drugs can promote cells to secrete antiviral interferons. These drugs target the SARS-CoV-2 virus, which causes COVID-19, and are also effective against multiple pathogenic RNA viruses.
Interferons are natural proteins that bolster the body’s immune system in combating infections and diseases such as cancer. They earned their name because they interfere with viruses, stopping them from spreading.

Both COVID-19 and some cancers activate the Wnt/beta-catenin pathway—a chain reaction inside the cell. Drugs that block this pathway, originally made to treat cancer, might also help fight COVID-19.

When the Wnt/beta-catenin pathway gets activated, it slows down the production of interferons. This pathway also negatively affects the immune system.

In a study, scientists tested two drugs, KYA1797K and E7449, that block the Wnt/beta-catenin pathway. They found that these drugs reduced the amount of virus in the lungs of mice. The drug E7449 was especially good at preventing weight loss and lung damage in the infected mice.
Related Stories
One in Five Pfizer Drug Users Experience COVID-19 Rebound: Study
11/14/2023
One in Five Pfizer Drug Users Experience COVID-19 Rebound: Study
Antiviral Drug May Shorten COVID-19-Induced Loss of Taste and Smell
10/24/2023
Antiviral Drug May Shorten COVID-19-Induced Loss of Taste and Smell

Tom Hobman, a professor of cell biology at the University of Alberta’s Faculty of Medicine and Dentistry and one of the study authors, explained in a statement that after using these drugs, cells produced interferons in response to viral infections at levels four to six times higher than before. Experiments also revealed that the virus was inactivated to less than one-ten-thousandth of its original levels.
Story continues below advertisement

He pointed out that interferons prevent infected cells from producing more viruses primarily in two ways: “It shuts down the infected cell, often resulting in cell death, and it also acts on the surrounding cells to prevent them from being infected.”
The researchers also tested viruses other than COVID-19 and found that the drugs exhibit broad-spectrum activity against a variety of RNA viruses. These include coronaviruses, responsible for seasonal respiratory infections, as well as mosquito-borne viruses such as Zika and Mayaro.
Ongoing Drug Trials for COVID-19
In addition to drugs targeting the Wnt/beta-catenin pathway, other drugs are also being explored for the potential to alleviate the COVID-19 virus.
A clinical trial published in February that involved 1,821 mild to moderate COVID-19 patients indicated that a drug called ensitrelvir significantly shortened the duration of symptoms in patients with COVID-19.
A phase II to III clinical trial of the anti-COVID-19 drug Simnotrelvir involving 1,208 patients with mild to moderate COVID-19 infection was published in the New England Journal of Medicine. The results show that patients who received Simnotrelvir treatment within 72 hours of COVID-19 symptom onset had their “time to sustained resolution of symptoms” shortened by 35.8 hours. In a subgroup with risk factors for severe COVID-19, Simnotrelvir reduced the time by 60 hours.
Natural Compounds With Antiviral Activity
In addition to drugs under development, some common plants and natural compounds also possess potent antiviral activity.
1. Iota-carrageenan
Iota-carrageenan is a polysaccharide extracted from red algae, commonly used as a thickener in puddings or ice creams. A study in Argentina involving 400 hospital workers indicates that a nasal spray containing iota-carrageenan could reduce the risk of contracting COVID-19 by about 80 percent.
2. Curcumin
A clinical trial published in the journal Nutrients in 2022 found that curcumin supplementation can effectively improve symptoms such as coughing, difficulty breathing, and muscle soreness in patients with mild to severe COVID-19. Compared to the control group, oxygen saturation was significantly higher in the treatment group.
3. Platycodon grandiflorum
A study proposed that platycodin D, a compound in Platycodon grandiflorum, is a potent natural product for preventing and treating COVID-19. The study found that Platycodon grandiflorum “effectively blocks” the entry of the COVID-19 virus into cells by altering the distribution of membrane cholesterol.
4. Reishi, Perilla, and Peppermint
Cell and animal experiments have demonstrated that extracts of Reishi mushroom, Perrila, and Chinese mint exhibit efficacy in inhibiting the COVID-19 virus. A particular compound in Reishi mushroom, Ganoderma lucidum, retains its antiviral effect even when diluted 1,280 times, with no cellular damage.
5. Green Tea and Black Tea
Tea polyphenols in green tea and black tea also have broad-spectrum antiviral effects. Animal experiments have found that catechins can inhibit coronavirus replication, enhance immunity, and improve acute lung injury. There are also studies indicating that tea catechins and catechin derivatives have the ability to effectively inactivate Omicron subvariants.
By Ellen Wan, Epoch Health Japan
3/30/2024
Updated:
4/2/2024
👍️0
Monroe1 Monroe1 4 weeks ago
LOL, we have a Mexican Standoff in the works. The desperados are fighting over the booty. LOL, no matter who wins, the loser will be reimbursed with tax payer money.
👍️0
Monroe1 Monroe1 4 weeks ago
Thanks for those links. Very informative for those that are concerned what may end up in their system.
Gave you a hit. Return it if you think deserved.
👍️0
Monroe1 Monroe1 4 weeks ago
Amen to that. Target Store and Amazon and many others joining in suing the crap out of PFE. My shorts are showing profits and may add more should this get a bit of kick up. Intermediate term prognosis is not good. Should the fool in the white house get replaced this stock will crash and rightfully so.
👍️0
IHuser IHuser 4 weeks ago
imo...ihub.com is the world's most distinguished securities discussion forum on the planet....if anybody wants to change the trajectory of this ticker....you will have to come through me and Vexari.... let's go~ NEXT! $PFE

PFE


IHuser
👍️0
DewDiligence DewDiligence 4 weeks ago
US_district_court pauses MRNA’s patent-infringement suit vs PFE/BNTX pending USPTO input:

https://www.reuters.com/legal/litigation/pfizer-wins-pause-modernas-covid-19-patent-lawsuit-2024-04-12/ Moderna's patent lawsuit claiming Pfizer and BioNTech copied its COVID-19 vaccine technology will be put on hold while the U.S. Patent Office determines whether two of the three Moderna patents at issue are valid, a Massachusetts federal court said on Friday.

U.S. District Judge Richard Stearns stayed the closely watched case over Moderna's objections after determining that the Patent Office's rulings would "simplify" the patent-infringement lawsuit, according to an entry on the court's docket.
👍️0
IHuser IHuser 4 weeks ago
imo... i was having a good time before the world went pandemic... much exposed ... if the people bury big pharma...i suppose it has been worth it huh Vex..? ...spirit of the warrior~


PFE

IHuser

👍️0
IHuser IHuser 1 month ago
imo... two short years ago.....bears on PFE board were certain that world government was doing population operations....and we felt helpless to interject with any sanity as to how inform innocents ...... today we sit post eclipse and see the sp tanking below the 25 dollar mark impending.... who says that ihub clowns don't run the show~


PFE


IHuser
💤 1 💩 1 🤡 1 🤮 1 🦃 1
IHuser IHuser 1 month ago
imo....one time Vex....my mom lied to me for the first time...PFE...do you know what she told me and it was no very nice~


she told me that the moon was made out of cheese~...

and fentanyl

how do you like that!!?


PFE


IHuser
💩 1 😎 1 🤡 1
Vexari Vexari 1 month ago
95% of Cheese

~~~ Infiltrated by Pfizer ~~~
(1:34)

It is what it is

KILLUMINATI13420
🤡 1 🦃 1

Your Recent History

Delayed Upgrade Clock